text_1: 紫杉醇 每周 用药 , 腹腔 内 化疗 和 贝伐珠 单抗 治疗 被 视为 可 接受 的 初始 治疗 2 - 5 .
  
text_2: the introductions of weekly paclitaxel therapy , intraperitoneal chemotherapy , and bevacizumab therapy are recognized alterations that are considered to be acceptable as primary therapy.2 @-@ 5
  